GERMANY PATENT SYSTEM – AN OVERVIEW

Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 2

Abstract

Patent is one of the intellectual property rights, by which the innovator gets exclusive rights or legal monopoly grated to an individual or a firm to make use or sell or reproduce and excluding others from doing so. The Germany patent act came into existence on June 21st 1976, which was taken from the European patent convention of October 5, 1973. Germany stands in 2nd place in filing patents and it shares 16% of total application in 2016 and 25.086 application are filed, grant of patent applications are 18,728. In this paper discussed about Germany patent system.

Authors and Affiliations

Priyanka Budime, Pooja Agarwal

Keywords

Related Articles

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF TELMISARTAN IN BULK AND TABLET DOSAGE FORM

A simple, sensitive, precise and specific reverse phase high performance liquid chromatographic method was developed and validated for the determination of Telmisartan in bulk and tablet dosage forms. It was found that t...

SELF-MEDICATION IN RELATION TO HEALTH LOCUS OF CONTROL

Present study was conducted to examine the association of self- medication and health locus of control. It was also intended to know the health problems for which people do self – medication and the medicines which are m...

Differentiation between the Regulatory paths placed on Mouthwashes in the US and EU

Regulating oral rinses has been and still is a topic of debate and confusion. Oral rinses are products that are mainly used for cleaning, perfuming and changing the appearance of the teeth, which in turn improves the ind...

Nanoparticles and target Drug delivery for cancer treatment: A Comprehensive review

In the healthcare industry, the biggest challenges are cancer. However, there are several drugs are available for the treatment of cancer. In these treatments cure cancer affecting the collateral toxicity to healthy cell...

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF DILTIAZEM HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP- HPLC

A simple, specific, precise and accurate Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method was developed and validated for the estimation of Diltiazem Hydrochloride in bulk and pharmaceutical dosage f...

Download PDF file
  • EP ID EP326708
  • DOI 10.22270/ijdra.v5i2.197
  • Views 148
  • Downloads 0

How To Cite

Priyanka Budime, Pooja Agarwal (2017). GERMANY PATENT SYSTEM – AN OVERVIEW. International Journal of Drug Regulatory Affairs, 5(2), 13-16. https://europub.co.uk/articles/-A-326708